Use of a new phosphate binder in chronic renal insufficiency.
D000328:Adult; D000368:Aged; D000535:Aluminum / Q000627:therapeutic use*; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D000537:Aluminum Oxide / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D000818:Animals; D004032:Diet; D004285:Dogs; D005260:Female; D005782:Gels; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D010710:Phosphates / Q000378:metabolism*; D010758:Phosphorus / Q000008:administration & dosage; D051381:Rats
D005782:Gels; D010710:Phosphates; C025173:basic aluminum carbonate gel; D010758:Phosphorus; D000536:Aluminum Hydroxide; C025174:controphos; D000535:Aluminum; D000537:Aluminum Oxide